Dan Gavrila, MD
Cardiovascular Disease · Weston, WINPI 1992818678
Payments from drug & device makers
Across 28 payments — averaging $99.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$254
- Medtronic$245
- Boston Scientific$187
- Cardiovascular Systems Inc.$16
- AstraZeneca$14
- plus $13 from 1 others
What the payments were for
- Travel & lodging$1,66660%
- Food & beverage$1,13040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 17 | $2,067 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $254 |
| Medtronic(2 entities) | 3 | $245 |
| Boston Scientific | 2 | $187 |
| Cardiovascular Systems Inc. | 1 | $16 |
| AstraZeneca | 1 | $14 |
| W. L. Gore & Associates, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mitra Clip system$1,371
- CoreValve Evolut$137
- NAVITOR$128
How this compares
$2,796 in reported general payments places this provider in the 60th percentile of 322 cardiovascular disease providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 71 | $76,258 |
| XareltoRivaroxaban | 38 | $30,849 |
| Repatha SureclickEvolocumab | 36 | $24,265 |
| Repatha SyringeEvolocumab | 19 | $18,804 |
| EntrestoSacubitril/Valsartan | 17 | $12,697 |
| Praluent PenAlirocumab | 12 | $6,091 |
| Metoprolol Succinate | 175 | $2,302 |
| Colchicine | 19 | $2,208 |
| ClopidogrelClopidogrel Bisulfate | 73 | $1,574 |
| Atorvastatin Calcium | 166 | $1,312 |
| Rosuvastatin Calcium | 103 | $1,228 |
| Amiodarone Hcl | 32 | $1,128 |
| Losartan Potassium | 26 | $1,118 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 73 | $1,039 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 44 | $867 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Weston
- David MurdockWausau$1.4M
- Ameer KabourAppleton$1.1M
- Eric RobertsMilwaukee$982K
- Timothy LogemannWausau$749K
- Paul HinderakerMadison$463K
- David PhamMadison$425K
- James RiderGreen Bay$389K
- Subhashish AgarwalBrookfield$378K
- Farhan RazaMadison$359K
- Renuka JainMilwaukee$340K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.